ABSTRACT
INTRODUCTION
Hearing loss is considered the most frequent sensory deficit in human populations, and it occurs at all ages worldwide [1] . Sensorineural hearing loss is the most common type of hearing loss, and it can be caused by various insults such as acoustic trauma, ear and brain tumors, aging, noise exposure, ototoxic medications, and chemicals. Sensorineural hearing loss cannot currently be medically treated [2] because of the irreversible death of hair cells (HCs) in the organ of Corti. Unlike birds or fish, effective HC regeneration has not been observed in the mature mammalian cochlea. Within the past few years, however, exciting animal research on genetic manipulation, gene therapy, and stem cell transplantation as well as new pharmaceutical agents have suggested that hearing loss might eventually be curable in the future.
In the mouse inner ear, supporting cells (SCs) have been shown to be a reliable source for regenerating HCs after damage in both the cochlea and the utricle [3] [4] [5] [6] [7] [8] [9] [10] . Previous studies have demonstrated that HC regeneration occurs by two mechanisms in neonatal cochlea: mitotic
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regeneration, in which a SC reenters the cell cycle and then several days later one or both daughter cells changes fate to become a HC; and direct trans-differentiation in which a SC directly differentiates into a HC without cell division [4, [10] [11] [12] [13] [14] . In the mouse cochlear sensory epithelium, HCs are interdigitated by SCs, and the loss of SCs will lead to the death of HCs [15, 16] . Thus, exhausting the supply of SCs to regenerate HCs is not an effective strategy for long-term HC regeneration. In contrast, inducing the SCs to reenter the cell cycle and mitotically generate HCs is a better strategy for HC regeneration. However, in previous reports the majority of regenerated HCs came from direct trans-differentiation, and mitotic HC regeneration only provided a small portion of the newly regenerated HCs.
Our efforts are focused on the promising future of genetic manipulation of two crucial signaling pathways during inner ear development, the Wnt/β-catenin signaling and the Notch signaling pathways [17, 18] . Canonical Wnt/β-catenin signaling is activated by the binding of Wnt ligand to the Frizzled receptor, which stops the ubiquitin-dependent proteolysis of β-catenin that results from the combined action of GSK3β and axin. Accumulated β-catenin then migrates from the cytoplasm to the nucleus where it associates with the TCF/Lef transcription factors and activates its downstream effector genes [19] . Wnt/β-catenin signaling has been reported to be involved in multiple events including proliferation, cell fate determination, differentiation and cell protection [20] [21] [22] [23] [24] . Wnt also has a dual function in the developing mouse auditory system by promoting the proliferation of Sox2-positive prosensories and specifying the number of HCs during development [11, 14, 25] . Lgr5 and Axin2 are two Wnt downstream genes in the cochlea [26, 27] . Activation of Wnt/β-catenin signaling initiates the proliferation of Lgr5 + cells, which are well established as progenitors for HCs in cochlea [11, 14, 28] . Unfortunately, only a small number of proliferating Lgr5 + progenitors trans-differentiate into HCs [10, 14, 29] . This suggests that although Wnt activation can increase the progenitor pool, Wnt activation alone cannot regenerate significant amounts of new HCs and thus is not an ideal approach for HC regeneration.
Notch signaling is well known for its lateral inhibition and feedback mechanisms that influence cell fate during HC differentiation [30] . Previous studies have shown that pharmacological or genetic disruption of Notch receptors such as notch1, Notch ligands such as Dll1 or Jag2, or key factors like γ-secretase lead to the inhibition of Notch signaling and thus induce SC to differentiate into HCs at the cost of exhausting the pool of SCs in both the cochlea and the vestibular organs [31] [32] [33] . Mutation or knockdown of downstream transcriptional effectors of Notch signaling, such as members of the Hes and Hey gene families, also have similar effects [34] [35] [36] [37] [38] [39] . However, HCs are interdigitated by the SCs and the loss of SCs will in turn lead to the death of HCs, including the newly differentiated HCs [10, 16, 40] . Thus, Notch inhibition alone is also not an ideal solution for long-term HC regeneration.
Based on previous research on both signaling pathways, we hypothesized that promoting the proliferation of SCs first and then letting the proliferated SCs differentiate into HCs would be the best approach to promote mitotic HC regeneration. Thus, we tested a two-step strategy to activate Wnt/β-catenin signaling first and then inhibit Notch signaling in the mouse cochlea to achieve our goal of mitotically regenerating the HCs. We found that Wnt activation followed by Notch inhibition significantly promotes SCs, including Lgr5 + progenitors, to mitotically regenerate new HCs with or without HC damage in the postnatal mouse cochlea.
RESULTS

The activation of Wnt/β-catenin signaling induces the proliferation of SCs with or without HC injury
Previous studies have reported that the activation of Wnt/β-catenin signaling induces the proliferation of Lgr5 + progenitors in the neonatal mouse cochlea [11] . Here, we first investigated the detailed effects of Wnt activation in all three turns of cultured mouse cochleae. 6-Bromoindirubin-3′-oxime (BIO), an effective GSK3β inhibitor, was used to pharmacologically activate the Wnt/β-catenin pathway [20, 21, [41] [42] [43] [44] [45] [46] in vitro. Cochleae were harvested from postnatal day (P)1 C57/BL6 mice and then cultured in DMEM/F12 media with 1 mM EdU and 5 μM BIO or 0.5% DMSO for 3 days ( Figure 1A) . No Sox2 + /EdU + cells were observed in the DMSO-treated control group (Figure 1B2-1D2, 1H and Supplementary  Table S1 ). Conversely, significantly more proliferating SCs, indicated by Sox2 + /EdU + cells, were observed in the apical and middle turns of the BIO-treated cochleae, while very few were seen in the basal turn (Figure 1E2-1G2,  1H and Supplementary Table S1 ). Moreover, there were no Myo7a + /EdU + cells (mitotically regenerated HCs) observed in either the DMSO-treated or BIO-treated cochleae ( Figure 1B1-1G1 ). These data demonstrate that activation of Wnt/β-catenin signaling induces the proliferation of SCs in the apical and middle turns of cultured cochleae but fails to successfully induce the proliferated SCs to differentiate into HCs.
Neomycin is widely used to create the HC damage model [47] . To investigate the detailed effect of Wnt activation in all three turns of the cultured cochleae after HC injury, 0.5 mM neomycin was added into the DMEM/ F12 media. This was followed by 1 mM EdU and 5 μM BIO or 0.5% DMSO, and the cochleae were cultured for another 3 days ( Figure 1I ). No Sox2 + /EdU + cells were observed in the DMSO-treated group (Figure 1J2-1L2,  1P and Supplementary Table S1) , while large numbers www.impactjournals.com/oncotarget of Sox2 + /EdU + cells were observed in the apical and middle turns of the BIO-treated cochleae (Figure 1M2-1N2, 1P and Supplementary Table S1 ). However, there was no significant difference in the basal turns between control and BIO-treated cochleae ( Figure 1L2 , 1O2, 1P and Supplementary Table S1 ). Consistent with the results in undamaged neonatal cochleae, few Myo7a + /EdU + cells were observed in either group after neomycin insult ( Figure 1J1-1O1 ). This result demonstrated that Wnt/β-catenin signaling activation only induced the proliferation of SCs after HC injury and failed to mitotically regenerate significant numbers of new HCs.
Samples from both groups were collected for quantitative RT-PCR to determine the RNA expression levels associated with Wnt and Notch signaling. BIO treatment significantly promoted the expression of the Wnt downstream genes Sp5, Axin2, and Lgr5, while the cell cycle inhibitor p27kip1 was inhibited ( Figure 1Q ). It is interesting that the expression of Notch signaling ligand Jag1 and downstream genes Hes1 and Hey1 were activated as well ( Figure 1Q ). This suggested that Wnt activation also activated Notch signaling, and the activation of Notch signaling could in turn inhibit the SCs from differentiating into HCs, which might be the reason that Wnt activation alone failed to induce the proliferated SCs to differentiate into HCs. In sum, these data indicate that Wnt/β-catenin signaling activation induces the proliferation of Sox2 + SCs in the apical and middle turns of cultured cochleae, and it also activates Notch signaling thus preventing the proliferated SCs from differentiating into HCs.
Inhibition of Notch signaling after Wnt/β-catenin activation promotes the mitotic regeneration of HCs and increases the total HC number
The experiments above showed that activating Wnt/β-catenin signaling activates Notch signaling and fails to induce the proliferated SCs to differentiate into HCs. Thus we proposed a two-step strategy in which Wnt signaling is first activated to promote SC proliferation and then Notch signaling is inhibited to promote the differentiation of SCs into HCs. In this experiment, we used Atoh1-eGFP transgenic mice in which HCs express eGFP [48] . A γ-secretase inhibitor (DAPT) was added to the culture media after 3 days of BIO treatment (Figure 2A Figure 2F ). In addition, BIO-DAPTtreated cochleae had significantly more eGFP + HCs in the apical and middle turns compared to the BIO-DMSO and control groups ( Figure 2G and Supplementary Table S2 ). When we compared the ratio of mitotically regenerated HCs in all eGFP + HCs, we found that BIO-DAPT-treated cochleae had significantly higher percentages of eGFP + / EdU + HCs in all three turns compared with the BIO-DMSO and control groups and in the middle and basal turns compared with the DMSO-DAPT group ( Figure 2H and Supplementary Table S2 ). To further verify this finding, we used another HC maker, Pou4f3, in a separate experiment. Pou4f3 staining also showed the similar result that there are significantly more Pou4f3 Table S8 ). These results demonstrated that suppressing Notch signaling following Wnt activation could significantly promote the mitotic regeneration of HCs and increase the total HC number.
The experiments above showed that both the BIO-DAPT group and the DMSO-DAPT group had significant numbers of eGFP Table S2 ). To determine whether these mitotically regenerated eGFP + HCs in the apex were mature HCs, the cochleae were stained with antibodies against Myo7a and Prestin. Myo7a is a more mature HC marker than Atoh1, and Prestin is a mature outer HC marker that begins to be expressed at P6. In the control group, all eGFP + cells in the apex were co-labeled with Myo7a, and no eGFP + /EdU + cells were observed ( Figure 3A1 -3A4, 3E, and 3F). In the BIO-DMSO group, the majority of eGFP Table S3 ). In contrast, it was very interesting that most of the eGFP + cells and 95.67 ± 2.27% of the eGFP + /EdU + cells in the BIO-DAPT group were also Myo7a + ( Figure 3D1 -3D4, 3E, 3F, and Supplementary Table S3 ). These data suggested that Notch signaling inhibition after Wnt/β-catenin signaling activation might help to promote the maturation of new mitotically regenerated HCs compared to Notch inhibition alone. To further verify this finding, in a separate experiment, we Supplementary Table S1. extended the culture duration from 8 days to 10 days, and stained with the mature HC maker Prestin. We found that after 10 days culture, Prestin + /EdU + HCs were observed in both DMSO-DAPT group and BIO-DAPT group; however, the number of Prestin + /EdU + HCs had no significantly difference between the two groups (Supplementary Figure  S3C2-S3D2, S3E and Supplementary Table S9 ).
After neomycin-induced injury, Wnt/β-catenin activation followed by Notch inhibition promotes the mitotic regeneration of HCs and increases the HC number in neonatal cochleae
To investigate whether the two-step strategy could also promote the mitotic regeneration of HCs and increase the total HC number after HC injury in vitro, cultured cochleae were injured with neomycin at P0 for 12 hours ( Figure 4A Figure 4F ). Moreover, after HC injury, BIO-DAPT-treated cochleae had significantly more total eGFP + HCs in all three turns compared to the BIO-DMSO and control groups and in the basal turn compared to the DMSO-DATP group ( Figure  4G and Supplementary Table S4 ). When we compared the ratio of mitotically regenerated HCs, we found that BIO-DAPT-treated cochleae also had the highest percentages of eGFP + /EdU + HCs among all eGFP + HCs in all three turns compared with all the other groups after HC injury ( Figure 4H and Supplementary Table S4 ). These results demonstrated that after neomycin-induced HC loss Wnt activation followed by Notch inhibition could significantly promote the mitotic regeneration of HCs and increase the total HC number.
The SC number in the BIO-DAPT group is partially restored compared with the DMSO-DAPT group
Previous studies have shown that inhibition of Notch signaling can induce the differentiation of SCs Supplementary Table S2. and that this leads to an increased number of HCs with a concomitant loss of SCs [31, 49, 50] . However, without considerable proliferation of SCs, the loss of SCs will lead to the eventual death of the regenerated HCs [15, 16] . Our experiments described above showed that with or without HC injury the majority of the mitotically regenerated HCs were in the apex, and both the BIO-DAPT group and DMSO-DAPT group had significant amounts of newly regenerated HCs in the apex with no significant difference between the two groups ( Figure 2F and 2G, Figure 4F and 4G, Supplementary Tables S2 and S4) . Thus, we next investigated the proliferation of SCs in the apical turns of the cochlea in both the BIO-DAPT and DMSO-DAPT groups. We counted the Sox2 + SCs in the organ of Corti (between the dashed lines in Figure 5 A2-F2 and A4-F4) and observed a few Sox2 + /EdU + SCs ( Figure  5A4-5F4) , and the number of SCs decreased dramatically in the apex of the DMSO-DAPT group both with and without HC injury ( Figure 5B1-4, 5E1-4 , 5G-5H, 5J-5K and Supplementary Table S5 ). In contrast, in the apex of the BIO-DAPT group we found significantly more Sox2 + / EdU + SCs, and the total SC number also increased to some extent compared to the DMSO-DAPT group with or without HC injury ( Figure 5C1-4 , 5F1-4, 5G-5H, 5J-5K and Supplementary Table S5). We found that the BIO-DAPT group also had a significantly higher SC/HC ratio than the DMSO-DAPT group in the apex with or without HC injury ( Figure 5I , 5L and Supplementary Table S5 ), suggesting that the HCs in the BIO-DAPT group might be better supported by the SCs. These results indicate that our two-step strategy could regenerate HCs while partially preserving the SC number, which might aid the survival of HCs. Thus, the two-step strategy might be a better approach for long-term HC regeneration. 
The majority of the mitotically regenerated HCs in the BIO-DAPT group originate from Lgr5
+ progenitor cells
To identify the origin of the new mitotically regenerated HCs, we used the Lgr5-eGFP-CreER/Rosa26-tdTomato mice for lineage tracing. We also used the apex as the material in this experiment because most of the mitotically regenerated HCs were in the apex. We found no Myo7a + /EdU + cells in the control group with or without damage ( Figure 7A1-7A4 injury. Also consistent with previous reports, our lineage tracing results showed that most of the proliferative SCs originated from Lgr5 + progenitor cells [11, 52, 53] . In this study we used BIO as a Wnt agonist to activate the Wnt signaling. BIO has been reported as an effective inhibitor for GSK3β, which activates canonical Wnt signaling and promotes cell proliferation in plenty of studies on different cell lines and auditory systems [20, 21, [41] [42] [43] [44] [45] [46] 54] . Although, as an inhibitor for GSK3 α/β, BIO also inhibits family of cyclin dependent kinases (CDKs), especially CDK5, in neurons [55] . Application of CDK5 inhibitors or expression of CDK inhibitors (CKIs) like p27Kip1, can trigger the differentiation of precursor cells in auditory development [56, 57] . And inhibition of the CKIs of the Cip/Kip family (p21Cip1, p27Kip1, and p57Kip2), especially the inhibition of p27Kip1, allow SC proliferation to occur [58] . However, there are no similar reports about BIO as an inhibitor for GSK3 α/β also inhibits CDKs in auditory organs.
There is evidence that BIO as an effective inhibitor for GSK3β activates wnt signaling and promotes cell proliferation via activating Jag1/Notch signaling and inhibiting p27Kip1 in cochlea [59, 60] ; here, we also observed the similar results. Our qRT-PCR results with the injured cochleae also showed that after Wnt activation with BIO treatment, the expression of Jag1, Hes1, and Hey1 in the Notch signaling pathway were also activated. Notch signaling has been well studied in inner ear development and prevents the surrounding SCs from differentiating into HCs via lateral inhibition [50, [61] [62] [63] [64] . Thus the activation of Notch signaling upon Wnt activation likely prevents the newly proliferated SCs from differentiating into HCs. Here, we found that very few eGFP + /EdU + cells were observed in the cochleae of the BIO-DMSO group with or without HC injury which also supports the notion that most of the proliferated SCs fail to differentiate into HCs after Wnt signaling activation alone. The Wnt correlated Notch signaling activation might also promote SCs proliferation and be responsible for preventing the proliferative SCs from differentiating ( Figure 7G ) [4, 60, 65, 66] . Coincident with the activation of Notch-related mRNA, our qRT-PCR results showed that BIO induced Wnt activation also accompanied with inhibition of p27Kip1, which would promote the Supplementary Table S6. proliferation of SCs [59, 67] . Taken together, activation of Wnt/β-catenin signaling can promote SCs proliferation but it alone was not able to initiate the differentiation of SCs. Moreover, previous studies reported that after Wnt activation, the number of proliferated Lgr5 + progenitors decreased at P21, suggesting that most of the proliferated Lgr5 + progenitors eventually undergo cell death without further differentiation in vivo [11] . This is supported by our observation that there was a significant decrease in the number of proliferated SCs from 3 days to 8 days after Wnt activation ( Figure S1 , Table S7 ). This process might be related to the activation of the cell-death pathway caused by the absence of retinoblastoma [40] or the activation of JNK signaling stimulated by non-canonical Wnt signaling via Dishevelled (Dvl) [68, 69] . Therefore, Wnt/β-catenin activation alone does not lead to successful HC regeneration in postnatal mice.
It is well established that the inhibition of Notch signaling is critical for the proper development of HCs and can induce the regeneration of HCs at the cost of exhausting the pool of SCs [32, 50, 64] . However, HCs, including the newly regenerated HCs, will also undergo cell death in absence of SCs [10, 16] . In this study, the number of HCs in the cochleae from the DMSO-DAPT group was also significantly increased accompanied by a sharp decrease in SC number. Although several mitotically regenerated HCs were also observed, which was consistent with our own recent report that inhibition of Notch signaling in Sox2 + SCs initiates mitotic regeneration of HCs [4] . Thus, Notch inhibition alone is also not an ideal strategy for long-term HC regeneration.
The failure of either of the two strategies above to induce HC regeneration on their own is the most important reason that current HC regeneration strategies have moved away from focusing on manipulating individual pathways or genes to the co-regulation of multiple pathways. A recent report in zebrafish also showed that localized interactions between the Notch and Wnt Pathways are required during regeneration of sensory hair cells [70] . In a separate experiment, we tried to stimulate Wnt signaling and suppress Notch signaling on neonatal transgene mice simultaneously. However, we found that simultaneously co-regulation of Wnt and Notch signaling produces tremendous proliferation within the prosensory domain without sufficient corresponding mitotic HC regeneration. These results led us to our two-step strategy in which we have used sequential manipulation of these two vital pathways, activating Wnt signaling first then inhibiting Notch signaling, to achieve a significant increase of the mitotic regeneration of HCs. We hypothesized that the ideal strategy for HC regeneration is to regenerate the HCs while preserving the SC number and this would require promoting SC proliferation first and then inducing the proliferated SCs to differentiate into HCs. Thus, we tested our strategy in which activated Wnt/β-catenin signaling promotes SC proliferation first and then inhibition of Notch signaling induces the differentiation of proliferated SCs into HCs. Despite the fact that EdU is unable to capture all of the proliferative cells due to its very short half-life, it is still very exciting that a considerable number of mitotically regenerated HCs were observed in the cochleae of the BIO-DAPT group with or without neomycin-induced HC injury. The total HC numbers in both the DMSO-DAPT and BIO-DAPT groups were significantly greater than the DMSO and BIO-DMSO groups with or without HC injury. Compared to the DMSO-DAPT group, the numbers of mitotically regenerated HCs and the ratio of mitotically regenerated HCs to all HCs were significantly higher in BIO-DAPT group. These results implied that combined with Wnt/β-catenin signaling activation, the occurrence of mitotic HC regeneration that primarily occurred in the apex in the DMSO-DAPT group could expand to the middle and basal turns. Our two-step strategy turns out to be more efficient than either individual treatment to promote mitotic HC regeneration. However, similar to previous reports [10, 71] , the newly regenerated HCs described in our two-step strategy still underwent incomplete maturation. Although almost all Atoh1-eGFP + /EdU + cells could be marked by the HC marker Myo7a, none of them could be labeled with the mature outer HC marker Prestin (data not shown). One possible reason for this could be that Prestin is a mature outer HC marker that is only starting to be expressed in outer HCs at P6. We cultured the P1 cochlea for 3 days with Wnt/β-catenin activation to induce SC proliferation and then for 5 days with Notch inhibition to regenerate HCs. Thus, even though the new HCs began to regenerate on the first day of Notch inhibition, 5 days might still not be long enough for the new HCs to be mature enough to express Prestin. When we longer the DAPT administration span from 5 days to 7 days, about 30% of Pou4f3 + /EdU + cells could be marked by Prestin. In addition, due to the conditions used to culture the whole cochleae, we could not observe the cochleae for longer time or with other factors that might be necessary for HCs to become fully mature. It would be of great interest to explore whether our two-step strategy would lead to better outcomes in in vivo experiments in the future. Transduction of Espn gene may also provide a new sight to promote regenerated HCs maturation [72] .
To determine the origin of the mitotically regenerated HCs, we lineage traced the Lgr5 + progenitors, and found the majority of mitotically regenerated HCs originated from the Lgr5 + progenitors in both injured and uninjured cochleae. This result further demonstrated that Lgr5 + progenitors are the most promising candidates for HC regeneration.
In summary, activation of Wnt/β-catenin signaling can induce the proliferation of SCs, including Lgr5 + progenitor cells. After this proliferation, Notch signaling inhibition can induce the proliferated SCs/ Lgr5 + progenitor cells to mitotically regenerate new HCs. Our results support our hypothesis that Wnt/β-catenin signaling activation followed by Notch signaling inhibition promotes mitotic regeneration of new HCs in the cochlea while partially preserving the SC number with or without HC damage. This study provides a promising two-step approach for the mitotic regeneration of HCs in vitro, and this approach would be a good basis for studying in vivo HC regeneration in mammalian animal experiments in the future.
MATERIALS AND METHODS
Animals
We used C57BL/6J wild type mice and three types of transgenic mice. Atoh1-EGFP [48] mice were obtained from Jane Johnson (University of Texas Southwestern Medical Center, Dallas), and Lgr5 eGFP-CreER (Stock 008875) [73] and Rosa26-tdTomato (Stock 007914) [74] mice were purchased from The Jackson Laboratory. The Atoh1-eGFP, Lgr5 eGFP-CreER , and Rosa26-tdTomato mice were genotyped with PCR (Supplementary Table S10 ). All animal experiments were approved by the Institutional Animal Care and Use Committee of Fudan University.
Cochlear explant cultures
Cochleae from postnatal day one (P1) mice were dissected in phosphate buffered saline (PBS, Hyclone) and cultured in DMEM/F12 (Hyclone) with 1% N2 supplement (Life Technologies), 2% B27 supplement (Life Technologies), and 50 µg/ml ampicillin (Sigma) at 37°C with 5% CO 2 . The explanted cochlea were treated with 0.5 mM neomycin sulfate (Sigma), 5 µM BIO-Acetoxime (Sigma), or 50 µM DAPT (γ-Secretase inhibitor IX). A final concentration of 10 µM EdU (5′-ethynyl-2′-deoxyuridine, Life Technologies) was added to the culture media throughout the entire culture period to label proliferative cells. Because BIO and DAPT were dissolved in DMSO (Sigma), DMSO was used for the vehicle control. During the culture, medium were changed every day; and when BIO administration was switched to DAPT, medium were simply removed without additional washing steps.
Immunohistochemistry
Cochleae were fixed with 4% (wt/vol) paraformaldehyde (Sigma) for 20 minutes. To detect cell proliferation, cochleae were permeabilized in PBS containing 1% Triton X-100 (1% PBS-T) for 15 minutes and labeled with the Click-iT EdU Imaging Kits (Life Technologies) according to the manufacturer's protocol. All cochleae were blocked with 1% PBS-T with 10% goat serum for 1 hour at room temperature. All antibodies were diluted in 1% PBS-T. Primary antibodies used in this study were rabbit anti-MyosinVIIa (1:800 dilution, Proteus BioSciences), goat anti-Sox2 (1:300 dilution, Santa Cruz), chicken anti-EGFP (1:1000 Abcam), and goat antiPrestin (1:1000 dilution, Santa Cruz). Appropriate Alexaconjugated secondary antibodies were used for detection. Nuclei were labeled with DAPI (1:1000 dilution, Sigma).
RNA extraction and real-time PCR
Total RNA isolation was carried out using Trizol (Life Technologies), and mRNA was reverse transcribed with the GoScript TM Reverse Transcription System (Promega) following the manufacturer's protocol. Primer pairs were designed using the online Primer3 software (http://frodo.wi.mit.edu/primer3/, Supplementary Table S11). Quantitative RT-PCR was performed using GoTaq 
Cell counting
Fluorescent Z-stack images were collected using a Leica TCS SP8 scanning confocal microscope. For cell counting, Z-projection was performed to project multiple slides of a Z-stack image to a single layer, and the number of Atoh1-eGFP + cells were counted in the apical, middle, and basal turns of the cochlea per 100 µm using ImageJ software.
Statistics
Results were expressed as mean ± SEM, and the statistical analyses were carried out in GraphPad Prism 6.0. Statistical significance was determined with unpaired Student's t-tests, and p < 0.05 was considered significant.
Further details about cochlear explant cultures, immunohistochemistry, RNA extraction, real-time PCR (primer sequences are listed in Supplemental Experimental Procedures with Table) , and cell counting are in the Supplemental Experimental Procedures.
Supplementary data
Supplementary data includes primer sequences for genotyping and qRT-PCR and 6 tables related to Figures 1-7 .
